#ESMO21
Eric Pujade-Lauraine reports on key results from ESMO Congress 2021 on LBA33 - Retreatment with maintenance olaparib in patients (pts) with ovarian cancer (OC) previously treated with a PARP inhibitor (PARPi): randomized Phase IIIb OReO/ENGOT Ov-38 trial
Produced by the European Society for Medical Oncology
http://www.esmo.org
Watch video #ESMO21 online without registration, duration hours minute second in high quality. This video was added by user European Society for Medical Oncology (ESMO) 17 September 2021, don't forget to share it with your friends and acquaintances, it has been viewed on our site 1,862 once and liked it 20 people.